Pulmonary Artery Enlargement: An Independent Risk Factor for Mortality in Patients Hospitalized With COVID-19
- PMID: 35880237
- PMCID: PMC9300717
- DOI: 10.1016/j.mayocpiqo.2022.07.001
Pulmonary Artery Enlargement: An Independent Risk Factor for Mortality in Patients Hospitalized With COVID-19
Abstract
Objective: To assess whether baseline pulmonary artery diameter (PAD), obtained from noncontrast nongated computed tomography (NCCT), can be associated with coronavirus disease 2019 (COVID-19) outcomes.
Patients and methods: This is a retrospective study of patients hospitalized with COVID-19 admitted to Hôtel-Dieu de France university hospital (Beirut, Lebanon) between March 1, 2020 and March 1, 2021. Pulmonary artery diameter was measured at baseline NCCT. Various outcomes were assessed, including hospital length of stay, intensive care unit admission, invasive mechanical ventilation, mortality, and Post-COVID-19 Functional Status scale at discharge and at 2-month follow-up.
Results: Four hundred sixty-five patients underwent baseline NCCT, including 315 men (67.7%) with a mean age of 63.7±16 years. Baseline PAD was higher in critically ill patients admitted to the intensive care unit (mean difference, 0.8 mm; 95% CI, 0.4-1.59 mm) and those receiving invasive mechanical ventilation (mean difference, 1.1 mm; 95% CI, 0.11-2.04 mm). Pulmonary artery diameter at baseline correlated significantly with hospital length of stay (r=0.130; P=.005), discharge status (r=0.117; P=.023), and with Post-COVID-19 Functional Status scale at 2-month follow-up (r=0.121; P=.021). Moreover, multivariable logistic regression showed that a PAD of 24.5 mm and above independently predicted in-hospital all-cause mortality remained unaffected in patients with COVID-19 (odds ratio, 2.07; 95% CI, 1.05-4.09).
Conclusion: Baseline PAD measurement using NCCT can be a useful prognostic parameter. Its measurement can help to identify early severe cases and adapt the initial management of patients hospitalized with COVID-19.
Keywords: COVID-19, coronavirus disease; NCCT, noncontrast nongated computed tomography; NEWS2, National Early Warning Score 2; PAD, pulmonary artery diameter; PCFS, Post–COVID-19 Functional Status; SARS-Cov-2, severe acute respiratory syndrome coronavirus 2.
© 2022 Published by Elsevier Inc on behalf of Mayo Foundation for Medical Education and Research.
Figures
Similar articles
-
Deep vein thrombosis and pulmonary embolism among hospitalized coronavirus disease 2019-positive patients predicted for higher mortality and prolonged intensive care unit and hospital stays in a multisite healthcare system.J Vasc Surg Venous Lymphat Disord. 2021 Nov;9(6):1361-1370.e1. doi: 10.1016/j.jvsv.2021.03.009. Epub 2021 Apr 6. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 33836287 Free PMC article.
-
Severe Acute Kidney Injury in Critically Ill Patients with COVID-19 Admitted to ICU: Incidence, Risk Factors, and Outcomes.J Clin Med. 2021 Mar 15;10(6):1217. doi: 10.3390/jcm10061217. J Clin Med. 2021. PMID: 33804100 Free PMC article.
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.JAMA Intern Med. 2020 Oct 1;180(10):1345-1355. doi: 10.1001/jamainternmed.2020.3539. JAMA Intern Med. 2020. PMID: 32667669 Free PMC article.
-
Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.J Transl Autoimmun. 2021;4:100083. doi: 10.1016/j.jtauto.2021.100083. Epub 2021 Jan 6. J Transl Autoimmun. 2021. PMID: 33521616 Free PMC article. Review.
Cited by
-
Reversibility of the Enlargement of the Pulmonary Artery in COVID-19 Pneumonia as a Marker of Remission of the Disease.J Pers Med. 2024 Jan 31;14(2):161. doi: 10.3390/jpm14020161. J Pers Med. 2024. PMID: 38392595 Free PMC article.
References
-
- Anon . 11 March 2020. WHO Director-General’s opening remarks at the media briefing on COVID-19.https://www.who.int/docs/default-source/coronaviruse/transcripts/who-aud... Accessed August 11, 2022.
-
- Anon. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Johns Hopkins Coronavirus Resource Center. Accessed August 11, 2022. https://ccp.jhu.edu/kap-covid/?gclid=CjwKCAjw0dKXBhBPEiwA2bmObW2oCu9s2Hb...
-
- Richardson S., Hirsch J.S., Narasimhan M., Crawford J.M., McGinn T., Davidson K.W., the Northwell COVID-19 Research Consortium Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323(20):2052–2059. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous